Pseudohypoaldosteronism Type 2Symptoms, Doctors, Treatments, Advances & More
Pseudohypoaldosteronism Type 2 Overview
Learn About Pseudohypoaldosteronism Type 2
Pseudohypoaldosteronism type 2 (PHA2) is caused by problems that affect regulation of the amount of sodium and potassium in the body. Sodium and potassium are important in the control of blood pressure, and their regulation occurs primarily in the kidneys.
PHA2 can be caused by mutations in the WNK1, WNK4, CUL3, or KLHL3 gene. These genes play a role in the regulation of blood pressure.
PHA2 is a rare condition; however, the prevalence is unknown.
This condition is usually inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases caused by mutations in the WNK1, WNK4, or KLHL3 gene, an affected person inherits the mutation from one affected parent. While some cases caused by CUL3 gene mutations can be inherited from an affected parent, many result from new mutations in the gene and occur in people with no history of the disorder in their family.
Shinichi Uchida practices practicing medicine in Tokyo, Japan. Mr. Uchida is rated as an Elite expert by MediFind in the treatment of Pseudohypoaldosteronism Type 2. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Pseudohypoaldosteronism Type 1, Pseudohypoaldosteronism Type 2, Bartter Syndrome, Nephrectomy, and Liver Embolization.
Eisei Sohara practices practicing medicine in Tokyo, Japan. Sohara is rated as an Elite expert by MediFind in the treatment of Pseudohypoaldosteronism Type 2. They are also highly rated in 21 other conditions, according to our data. Their clinical expertise encompasses Pseudohypoaldosteronism Type 1, Pseudohypoaldosteronism Type 2, Bartter Syndrome, Nephrectomy, and Liver Embolization.
Takayasu Mori practices practicing medicine in Tokyo, Japan. Mori is rated as an Elite expert by MediFind in the treatment of Pseudohypoaldosteronism Type 2. They are also highly rated in 25 other conditions, according to our data. Their clinical expertise encompasses Pseudohypoaldosteronism Type 2, Pseudohypoaldosteronism Type 1, Nephronophthisis, Mastectomy, and Nephrectomy.
Summary: The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research. The purpose of this research is to: * Develop Clinical Guidelines for specific rare kidney diseases. These are written recommendations on how to diagnose and treat a medical condition. * Audit treatments and outcomes. An audit makes checks to see if ...
Published Date: March 01, 2016
Published By: National Institutes of Health